ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trif...

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Acids, Heterocyclic ∟ Nicotinic Acids ∟ 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester 19 coordinate concepts ∟ Arecoline \| ∟ Clonixin \| ∟ Etazolate \| ∟ Niacin \| ∟ Niacinamide \| ∟ Niceritrol \| ∟ Niflumic Acid \| ∟ Nimodipine \| ∟ Pipemidic Acid \| ∟ Piromidic Acid \| ∟ Xanthinol Niacinate \| ∟ Amlodipine \| ∟ Dicarbethoxydihydrocollidine \| ∟ Felodipine \| ∟ Isradipine \| ∟ Nicardipine \| ∟ Nifedipine \| ∟ Nisoldipine \| ∟ Nitrendipine Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Pyridines ∟ Dihydropyridines ∟ 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester 19 coordinate concepts ∟ Arecoline \| ∟ Clonixin \| ∟ Etazolate \| ∟ Niacin \| ∟ Niacinamide \| ∟ Niceritrol \| ∟ Niflumic Acid \| ∟ Nimodipine \| ∟ Pipemidic Acid \| ∟ Piromidic Acid \| ∟ Xanthinol Niacinate \| ∟ Amlodipine \| ∟ Dicarbethoxydihydrocollidine \| ∟ Felodipine \| ∟ Isradipine \| ∟ Nicardipine \| ∟ Nifedipine \| ∟ Nisoldipine \| ∟ Nitrendipine Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Pyridines ∟ Nicotinic Acids ∟ 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester 19 coordinate concepts ∟ Arecoline \| ∟ Clonixin \| ∟ Etazolate \| ∟ Niacin \| ∟ Niacinamide \| ∟ Niceritrol \| ∟ Niflumic Acid \| ∟ Nimodipine \| ∟ Pipemidic Acid \| ∟ Piromidic Acid \| ∟ Xanthinol Niacinate \| ∟ Amlodipine \| ∟ Dicarbethoxydihydrocollidine \| ∟ Felodipine \| ∟ Isradipine \| ∟ Nicardipine \| ∟ Nifedipine \| ∟ Nisoldipine \| ∟ Nitrendipine X
Broader terms:	Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Acids, Heterocyclic ∟ Nicotinic Acids ∟ 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Pyridines ∟ Dihydropyridines ∟ 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Pyridines ∟ Nicotinic Acids ∟ 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester Nicotinic Acids > Acids, Heterocyclic > Heterocyclic Compounds > Medical Subject Headings (MeSH) Dihydropyridines > Pyridines > Heterocyclic Compounds, 1-Ring > Heterocyclic Compounds > Medical Subject Headings (MeSH) Nicotinic Acids > Pyridines > Heterocyclic Compounds, 1-Ring > Heterocyclic Compounds > Medical Subject Headings (MeSH) X
Annotation:	a calcium channel agonist X
History note:	Nifedipine/analogs & derivatives (1975-1986) \| Pyridines (1966-1974)X
historyNote*:	87 X
publicMeSHNote*:	87 X
Scope note:	A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. It is used primarily as a research tool. X
activeMeSHYear*:	2007X
dateCreated*:	1986-06-02X
dateEstablished*:	1987-01-01X
dateRevised*:	2006-07-05X
recordAuthorizer*:	sjnX
recordMaintainer*:	agsX
recordOriginator*:	RLSX
Type:	Concept X
Coordinate terms:	Arecoline \| Clonixin \| Etazolate \| Niacin \| Niacinamide \| Niceritrol \| Niflumic Acid \| Nimodipine \| Pipemidic Acid \| Piromidic Acid \| Xanthinol Niacinate \| Amlodipine \| Dicarbethoxydihydrocollidine \| Felodipine \| Isradipine \| Nicardipine \| Nifedipine \| Nisoldipine \| Nitrendipine X
URI:	X
Labels and equivalent concepts:	Bay-K-8644 (fi) 3-pyridinkarboxylsyra, 1,4-dihydro-2,6-dimetyl-5-nitro-4-(2-(trifluormetyl)fenyl)-,metylester (sv) Bay-K-8644 (sv, replaced) 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester (en) BK-8644 (en, replaced) Bay-K8644 (en, replaced) Bay R5417 (en, replaced) X
Share:	X